Sucampo Pharmaceuticals Archives

Press ESC key to close search

Deutsche Supports Mallinckrodt/Sun Acquisition Merger

Mallinckrodt entered into an agreement to merge Sun Acquisition and Sucampo Pharmaceuticals. Deutsche Bank agented a $900 million revolving credit facility to support the transaction.

Deutsche Bank Provides $500MM Term Loan for Mallinckrodt Sucampo Purchase

Mallinckrodt agreed to acquire biopharmaceutical company Sucampo Pharmaceuticals, including its commercial and development assets, for $1.2 billion. The transaction was approved by the boards of directors of both companies.

December 27, 2017 Deutsche Bank | Deutsche Bank Securities | Mallinckrodt | Sucampo Pharmaceuticals Amanda Koprowski

Jefferies Agents $250MM for Sucampo to Support Acquisition

Sucampo Pharmaceuticals announced the closing of term loans in the aggregate amount of $250 million in connection with the financing of its acquisition of R-Tech Ueno.

October 23, 2015 Jefferies Finance | Sucampo Pharmaceuticals Rita Garwood

<img width="200" src="https://www.abfjournal.com/wp-content/uploads/2020/02/abfj-logo-web-header1-blue.png" alt="ABFJournal" />

Tag Archives: Sucampo Pharmaceuticals

Deutsche Supports Mallinckrodt/Sun Acquisition Merger

Deutsche Bank Provides $500MM Term Loan for Mallinckrodt Sucampo Purchase

Jefferies Agents $250MM for Sucampo to Support Acquisition